Annovis Bio Announces Statistically Significant Phase II/III Data in Patients With Early Alzheimer’s Disease
April 29, 2024 10:10 ET
|
Annovis Bio Inc.
Significantly higher rate of improvement in ADAS-Cog 11 scores in each treatment dose relative to placebo for patients with mild ADImprovement in cognition measured by ADAS-Cog 11 at three months is...
Novo Nordisk A/S – Total number of voting rights and share capital in Novo Nordisk A/S as of 26 April 2024
April 26, 2024 06:16 ET
|
Novo Nordisk A/S
Bagsværd, Denmark, 26 April 2024 – In accordance with Section 32 of the Danish Capital Markets Act, Novo Nordisk A/S is required to publish the total number of voting rights and the size of the share...
NorthWestern Reports First Quarter 2024 Financial Results
April 25, 2024 19:25 ET
|
NorthWestern Corporation
BUTTE, Mont. and SIOUX FALLS, S.D., April 25, 2024 (GLOBE NEWSWIRE) -- NorthWestern Energy Group, Inc. d/b/a NorthWestern Energy (Nasdaq: NWE) reported financial results for the three months ended...
Boys & Girls Clubs of Delaware, Navient to host May 4 college planning conference
April 25, 2024 14:06 ET
|
Navient Corporation
DOVER, Del., April 25, 2024 (GLOBE NEWSWIRE) -- Boys & Girls Clubs of Delaware, a seasoned leader in youth development, and Navient (Nasdaq: NAVI), a leader in technology-enabled education...
NANO MAGIC UPDATE
April 24, 2024 09:00 ET
|
Nano Magic, Inc.
Madison Heights, Michigan, April 24, 2024 (GLOBE NEWSWIRE) -- Nano Magic, Inc. (OTC: NMGX) (“Nano Magic” or the “Company”), a leader in innovative nanotechnology powered cleaning solutions,...
Novo Nordisk A/S – Reduction of the share capital
April 24, 2024 08:48 ET
|
Novo Nordisk A/S
Bagsværd, Denmark, 24 April 2024 – At Novo Nordisk’s Annual General Meeting on 21 March 2024, it was decided to reduce the company’s B share capital from DKK 343,512,800 to DKK 339,012,800 by...
Altamira Therapeutics Announces Publication of Positive Results from Bentrio Trial in Seasonal Allergic Rhinitis in Top Peer Reviewed Journal
April 24, 2024 08:47 ET
|
Altamira Therapeutics Ltd
Hamilton, Bermuda, April 24, 2024 (GLOBE NEWSWIRE) -- Detailed results from randomized controlled Bentrio® trial in seasonal allergic rhinitis published in Allergy journal Study met primary...
NeoVolta Announces Ardes Johnson as New CEO
April 24, 2024 08:45 ET
|
NeoVolta Inc.
SAN DIEGO, April 24, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: NEOV) – NeoVolta Inc., a San Diego-based leader in smart energy storage solutions, is thrilled to announce the appointment of Ardes Johnson as...
Novo Nordisk A/S - share repurchase programme
April 22, 2024 09:06 ET
|
Novo Nordisk A/S
Bagsværd, Denmark, 22 April 2024 – On 6 February 2024, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council...
Blind Logic Productions Partners with Video Caption Corporation for Accessible Documentary Film "Blind Logic"
April 17, 2024 22:46 ET
|
Blind Logic Production
Los Angeles, CA, April 17, 2024 (GLOBE NEWSWIRE) -- Blind Logic Productions announced the association with Video Caption Corporation for the creation of an Audio Description (AD) track for their...